ASCENDIS PHARMA A/S

Company

Ascendis Pharma A/S

Filed

October 8, 2020

Accession Number

0001193125-20-265872

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →